Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Diagnosis and Classification of Abdominal Compartment Syndrome

Diagnosis and Classification of Abdominal Compartment Syndrome

Objective Icon A checkmark inside a circle, symbolizing an achieved goal.

Objective

Apply diagnostic and classification criteria to assess abdominal compartment syndrome (ACS) and guide initial management.

1. Clinical Presentation and Physical Examination

Early suspicion of ACS arises from a combination of abdominal findings and multisystem signs. Physical exam alone is unreliable; objective measurement of intra‐abdominal pressure (IAP) is essential.

Abdominal exam:

  • Progressive distension, increased wall tension, discomfort on palpation
  • Guarding or rigidity may mimic peritonitis but lack specificity

Systemic signs:

  • Oliguria/anuria despite adequate fluid status
  • Hypotension with escalating vasopressor requirements
  • Rising peak airway pressures and worsening respiratory compliance

Red flags:

  • Sudden lactate rise, refractory metabolic acidosis
  • Rapid decline in mental status or escalating ventilator settings
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Exam Unreliability

Never rely solely on abdominal exam to exclude Intra-Abdominal Hypertension (IAH) or Abdominal Compartment Syndrome (ACS).

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Respiratory Clues

Rising airway pressures in a ventilated patient may reflect increased IAP and warrant direct measurement.

2. Laboratory and Physiologic Markers

Laboratory trends and hemodynamic parameters reveal evolving organ dysfunction secondary to elevated IAP.

Key Laboratory and Physiologic Markers in Suspected ACS
Marker/Parameter Significance in IAH/ACS Target/Monitoring Note
Serum Creatinine & BUN Indicates renal hypoperfusion and acute kidney injury (AKI). Monitor trends; apply KDIGO criteria for AKI staging.
Lactate & Base Deficit (ABG) Reflects tissue hypoperfusion and metabolic acidosis. Trend to gauge response to decompression efforts; rising values are ominous.
Central Venous Pressure (CVP) Often elevated due to decreased abdominal venous return and direct caval compression. Interpret in context of IAP; may not reflect true intravascular volume.
Cardiac Output (CO) Decreased due to reduced preload (caval compression) and increased afterload (systemic vascular resistance). Monitor via PAC or non-invasive methods if available.
Abdominal Perfusion Pressure (APP) Calculated as MAP – IAP. Reflects visceral perfusion pressure. Aim for APP >50–60 mmHg.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: APP Utility

Abdominal Perfusion Pressure (APP) may better predict visceral perfusion and risk of organ failure than Mean Arterial Pressure (MAP) alone in the setting of IAH.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Lactate Interpretation

Trending lactate helps differentiate volume-responsive hypoperfusion from pressure-mediated hypoperfusion due to IAH/ACS.

3. Imaging and Adjunctive Modalities

Point‐of‐care ultrasound (POCUS) and CT imaging complement clinical assessment, identify etiologies, and guide interventions.

Ultrasound (POCUS):

  • Detect free fluid (ascites), bowel wall edema, venous congestion (e.g., VExUS score components).
  • Guide percutaneous drainage when indicated.

Computed Tomography (CT):

  • Identify visceral edema, large fluid collections, or specific pathology like pancreatic necrosis in pancreatitis.
  • “Round-belly sign”: An anteroposterior (AP) to transverse abdominal diameter ratio >0.8 suggests IAH.
“Round-Belly Sign” (AP/Transverse Ratio > 0.8)
AP Diameter
Transverse Diameter
Increased IAP leads to AP diameter ≈ Transverse diameter
Figure 1: The “Round-Belly Sign”. On axial CT imaging, an anteroposterior (AP) abdominal diameter that approaches or exceeds the transverse diameter (ratio >0.8) is suggestive of increased intra-abdominal pressure. This sign is particularly noted in conditions like acute pancreatitis with significant fluid collections or visceral edema.

Emerging tools:

Intragastric pressure monitoring and elastography are being investigated but are not yet standard practice. [Editor’s Note: Insufficient source material for detailed protocols on these modalities was provided for this chapter.]

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Round-Belly Sign in Pancreatitis

The round-belly sign on CT strongly correlates with IAH, especially in patients with acute pancreatitis and significant retroperitoneal/intraperitoneal fluid or inflammation.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: POCUS for Triage

Use POCUS early to assess for free fluid, bowel edema, and signs of venous congestion to help triage patients at risk for IAH/ACS and guide potential decompressive interventions like paracentesis.

4. Intra‐Abdominal Pressure Measurement Protocol

Standardized trans‐bladder technique remains the reference standard for IAP monitoring.

Procedure:

  1. Setup:
    • Ensure patient is supine.
    • Connect the Foley catheter drainage port to a pressure transducer system.
    • Zero the transducer at the mid‐axillary line, level with the iliac crest (phlebostatic axis).
  2. Instillation and Measurement:
    • Ensure bladder is empty.
    • Instill a maximum of 25 mL sterile saline into the bladder via the aspiration port of the Foley catheter.
    • Wait 30-60 seconds for detrusor muscle relaxation.
    • Record the IAP (in mmHg) at end‐expiration to minimize respiratory variation.
  3. Monitoring Frequency:
    • Obtain a baseline measurement in all at‐risk patients.
    • Repeat measurements every 4–6 hours, or more frequently if clinically indicated (e.g., after large volume resuscitation, new organ dysfunction, or any abdominal intervention).

Common Pitfalls in IAP Measurement:

Common Pitfalls in Trans-Bladder IAP Measurement
Pitfall Consequence Prevention/Correction
Overfilling bladder (>25 mL saline) Falsely elevated IAP reading due to bladder distension. Use ≤25 mL instillation volume.
Incorrect transducer zeroing Inaccurate IAP readings (falsely high or low). Zero transducer at iliac crest in mid-axillary line with patient supine. Re-zero if patient position changes.
Patient not supine or HOB elevated Falsely elevated IAP. Ensure patient is flat and supine for measurement.
Measurement during inspiration or coughing Falsely elevated IAP. Measure at end-expiration, ensuring patient is calm and abdominal muscles relaxed.
Air in tubing or transducer Dampened waveform, inaccurate reading. Ensure system is free of air bubbles.
Blocked or kinked catheter Inability to instill fluid or obtain accurate pressure. Ensure catheter patency before measurement.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Instillation Volume

Keep saline instillation volume at ≤25 mL to avoid artifactual pressure readings from bladder overdistension.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: End-Expiration Measurement

Always measure IAP at end‐expiration to ensure consistency and minimize influence from respiratory mechanics.

5. Classification and Severity Stratification

Grading Intra-Abdominal Hypertension (IAH) and defining Abdominal Compartment Syndrome (ACS) facilitates risk stratification and guides escalation of care, based on WSACS consensus definitions.

  • Intra-Abdominal Hypertension (IAH) Definition: Sustained or repeated pathological elevation in IAP ≥12 mmHg.
  • Abdominal Compartment Syndrome (ACS) Definition: Sustained IAP >20 mmHg that is associated with new organ dysfunction/failure.
WSACS Grading of Intra-Abdominal Hypertension (IAH)
IAH Grade Sustained Intra-Abdominal Pressure (IAP) Clinical Implication
Grade I 12–15 mmHg Monitor closely; initiate conservative measures.
Grade II 16–20 mmHg Increased risk of organ dysfunction; intensify conservative measures. Consider interventions if organ dysfunction present.
Grade III 21–25 mmHg High likelihood of ACS if organ dysfunction present. Prepare for decompressive interventions.
Grade IV >25 mmHg Often associated with overt ACS. Urgent decompression usually required.

Risk scores and decision tools:

  • Integrate IAP measurements with clinical signs of organ dysfunction (e.g., using SOFA score changes).
  • Consider individualized IAP thresholds for concern in patients with pre-existing limited physiological reserve (e.g., severe sepsis, cirrhosis, baseline organ impairment).
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Individualized Thresholds

Organ dysfunction may occur at lower IAP levels (e.g., IAP 15-20 mmHg) in patients with underlying conditions like sepsis, cirrhosis, or pre-existing organ impairment. ACS is defined by IAP >20 mmHg PLUS new organ dysfunction.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Grading for Action

Use IAH grading to trigger protocolized interventions, including medical management escalation and timely surgical consultation for potential decompression.

6. Algorithmic Approach to Initial Management

Management escalates from conservative measures to surgical decompression based on IAH grade and the presence or progression of organ dysfunction.

Figure 2: Initial Management Algorithm for IAH/ACS
Flowchart depicting management of Intra-Abdominal Hypertension and Abdominal Compartment Syndrome.
Patient at Risk for IAH/ACS
Measure baseline IAP
IAH Grade I–II (IAP 12–20 mmHg)
No overt new organ failure
Medical Management / Conservative Measures:
  • Optimize fluid balance (avoid overload)
  • Enhance sedation/analgesia
  • Consider prokinetics for ileus
  • NG/rectal tube decompression
  • Monitor IAP q4-6h & organ function
IAH Grade III (IAP 21–25 mmHg) OR
IAP 12-20 mmHg WITH Early/New Organ Dysfunction
Escalate Medical Management:
  • Trial neuromuscular blockade (if ventilated)
  • Consider diuretics / CRRT for de-resuscitation
  • Percutaneous catheter drainage (if fluid dominant)
  • Monitor IAP frequently & organ function
  • Surgical consult
ACS (IAP >20 mmHg WITH New Organ Dysfunction) OR
IAH Grade IV (IAP >25 mmHg)
Urgent Decompression:
  • Surgical consultation for decompressive laparotomy
  • Manage open abdomen (e.g., NPWT)
  • Optimize hemodynamics & organ support
This algorithm provides a general framework. Clinical judgment and individual patient factors are paramount. APP = Abdominal Perfusion Pressure; IAP = Intra-Abdominal Pressure; NPWT = Negative Pressure Wound Therapy.

Key Points for Management:

Key Point IconA shield with an exclamation mark, indicating a key point. Key Point: Early Action

Early recognition of IAH and protocolized escalation of care can reduce progression to ACS and irreversible organ damage.

Key Point IconA shield with an exclamation mark, indicating a key point. Key Point: Team Approach

Multidisciplinary coordination involving critical care, surgery, nursing, and pharmacy is vital for optimal patient outcomes in IAH/ACS.

References

  1. Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra‐abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines. Intensive Care Med. 2013;39(7):1190–1206.
  2. Zarnescu NO, Dumitrascu I, Zarnescu EC, et al. Abdominal Compartment Syndrome in Acute Pancreatitis: A Narrative Review. Diagnostics. 2023;13(1):1–17.
  3. Vella MA, Kaplan LJ. What Is Abdominal Compartment Syndrome and How Should It Be Managed? In: Asensio JA, Trunkey DD, editors. Current Therapy of Trauma and Surgical Critical Care. 3rd ed. Elsevier; 2025. p.541–547.
  4. Sugrue M, Bauman A, Jones F, et al. Clinical examination is an inaccurate predictor of intraabdominal pressure. World J Surg. 2002;26(12):1428–1431.
  5. Cheatham ML, White MW, Sagraves SG, et al. Abdominal perfusion pressure: a superior parameter in the assessment of intra‐abdominal hypertension. J Trauma. 2000;49(4):621–627.
  6. Gupta P, Kamat R, Samanta J, et al. Computed Tomography Findings in Intraabdominal Hypertension in Patients with Acute Pancreatitis. Indian J Radiol Imaging. 2021;31(2):150–156.
  7. Pereira BM, Pereira RG, Wise R, et al. The role of point‐of‐care ultrasound in intra‐abdominal hypertension management. Anaesthesiol Intensive Ther. 2017;49(5):373–381.
  8. Jacobs R, Wise RD, Myatchin I, et al. Fluid Management, Intra‐Abdominal Hypertension and the Abdominal Compartment Syndrome: A Narrative Review. Life. 2022;12(9):1390.
  9. Peng T, Dong LM, Zhao X, et al. Minimally invasive percutaneous catheter drainage versus open laparotomy with temporary closure for treatment of abdominal compartment syndrome in early-stage severe acute pancreatitis. J Huazhong Univ Sci Technol Med Sci. 2016;36(1):99–105.